Therapeutic efficacy of Sunitinib and other broad spectrum receptor tyrosine kinase inhibitors (RTKI) in bleomycin-induced pulmonary fibrosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-9255
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Therapeutic efficacy of Sunitinib and other broad spectrum receptor tyrosine kinase inhibitors (RTKI) in bleomycin-induced pulmonary fibrosis ; volume:10 ; number:1 ; day:14 ; month:8 ; year:2013 ; pages:1 ; date:8.2013
Journal of Inflammation ; 10, Heft 1 (14.8.2013), 1, 8.2013
- Urheber
-
Knoerzer, D.
- Beteiligte Personen und Organisationen
-
Baginski, T.
Wade, K.
Fan, C.
Rapp, S.
Regina, K.
Shih, F.
Burney, M.
Rouw, S.
Welsch, D.
SpringerLink (Online service)
- DOI
-
10.1186/1476-9255-10-S1-P38
- URN
-
urn:nbn:de:1111-2016073036494
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Knoerzer, D.
- Baginski, T.
- Wade, K.
- Fan, C.
- Rapp, S.
- Regina, K.
- Shih, F.
- Burney, M.
- Rouw, S.
- Welsch, D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
A critical role of AREG for bleomycin-induced skin fibrosis
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
Bleomycin-induced genome structural variations in normal, non-tumor cells
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
Gut microbiota modulates bleomycin-induced acute lung injury response in mice
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
A critical role of AREG for bleomycin-induced skin fibrosis
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
Bleomycin-induced genome structural variations in normal, non-tumor cells
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
Gut microbiota modulates bleomycin-induced acute lung injury response in mice
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
A critical role of AREG for bleomycin-induced skin fibrosis
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
Bleomycin-induced genome structural variations in normal, non-tumor cells
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
Gut microbiota modulates bleomycin-induced acute lung injury response in mice